Additionally, studies have demonstrated reduced expression of UBE2L6 in primary acute myeloid leukemia (AML) cells, where silencing UBE2L6 inhibits ATRA-induced ISG15 conjugation, thus impairing isgylation and hindering AML cell differentiation (43). The gene discussed is UBE2L6; the disease is acute myeloid leukemia.